Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Solomon

Showing results (1291-1300 of 1,388) with videos related to

Pageof 139
Sort By:
The European Respiratory Journal|November 21, 2015
Predictors of mortality in rheumatoid arthritis-associated interstitial lung diseaseJoshua J Solomon, Jonathan H Chung, Gregory P Cosgrove, et al.
JCO Precision Oncology|August 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for DeliveryKortnye Smith, Sophie O'Haire, Benjamin Markman, et al.
JTO Clinical and Research Reports|July 22, 2024
Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 TrialBenjamin J Solomon, Ibiayi Dagogo-Jack, Se-Hoon Lee, et al.
The New England Journal of Medicine|April 10, 2024
Alectinib in Resected <i>ALK</i>-Positive Non-Small-Cell Lung CancerYi-Long Wu, Rafal Dziadziuszko, Jin Seok Ahn, et al.
The Lancet. Oncology|March 15, 2016
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trialDong-Wan Kim, Ranee Mehra, Daniel S W Tan, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Seminars in Arthritis and Rheumatism|September 8, 2021
Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 processDavid Roofeh, Shaney L Barratt, Athol U Wells, et al.
Preventive Medicine|March 6, 2022
Randomized Controlled Trial Examining the Efficacy of Adding Financial Incentives to Best practices for Smoking Cessation Among pregnant and Newly postpartum WomenStephen T Higgins, Tyler D Nighbor, Allison N Kurti, et al.
The New England Journal of Medicine|March 28, 2014
Ceritinib in ALK-rearranged non-small-cell lung cancerAlice T Shaw, Dong-Wan Kim, Ranee Mehra, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2020
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid TumorsLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Pageof 139

Showing results (1291-1300 of 1,388) with videos related to

Sort By:
Pageof 139
The European Respiratory Journal|November 21, 2015
Predictors of mortality in rheumatoid arthritis-associated interstitial lung diseaseJoshua J Solomon, Jonathan H Chung, Gregory P Cosgrove, et al.
JCO Precision Oncology|August 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for DeliveryKortnye Smith, Sophie O'Haire, Benjamin Markman, et al.
JTO Clinical and Research Reports|July 22, 2024
Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 TrialBenjamin J Solomon, Ibiayi Dagogo-Jack, Se-Hoon Lee, et al.
The New England Journal of Medicine|April 10, 2024
Alectinib in Resected <i>ALK</i>-Positive Non-Small-Cell Lung CancerYi-Long Wu, Rafal Dziadziuszko, Jin Seok Ahn, et al.
The Lancet. Oncology|March 15, 2016
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trialDong-Wan Kim, Ranee Mehra, Daniel S W Tan, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Seminars in Arthritis and Rheumatism|September 8, 2021
Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 processDavid Roofeh, Shaney L Barratt, Athol U Wells, et al.
Preventive Medicine|March 6, 2022
Randomized Controlled Trial Examining the Efficacy of Adding Financial Incentives to Best practices for Smoking Cessation Among pregnant and Newly postpartum WomenStephen T Higgins, Tyler D Nighbor, Allison N Kurti, et al.
The New England Journal of Medicine|March 28, 2014
Ceritinib in ALK-rearranged non-small-cell lung cancerAlice T Shaw, Dong-Wan Kim, Ranee Mehra, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2020
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid TumorsLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Pageof 139